Ryvu Therapeutics S.A. (WSE:RVU)
Poland flag Poland · Delayed Price · Currency is PLN
33.50
+1.35 (4.20%)
May 9, 2025, 5:03 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Novel Small Molecule Therapies
46.86M
Log In
Log In
Log In
Log In
Novel Small Molecule Therapies Growth
20.32%
Log In
Log In
Log In
Log In
Service
-
Log In
Log In
Log In
Log In
Service Growth
-
Log In
Log In
Log In
Log In
Bioinformatics
-
Log In
Log In
Log In
Log In
Bioinformatics Growth
-
Log In
Log In
Log In
Log In
Exclusion Income between Segments
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
European Union Countries
41.66M
Log In
Log In
Log In
Log In
European Union Countries Growth
69.25%
Log In
Log In
Log In
Log In
Other Countries
5.16M
Log In
Log In
Log In
Log In
Other Countries Growth
-63.73%
Log In
Log In
Log In
Log In
Poland
38.00K
Log In
Log In
Log In
Log In
Poland Growth
-64.15%
Log In
Log In
Log In
Log In
United States
-
Log In
Log In
Log In
Log In